Transactivation functions of the N-terminal domains of nuclear hormone receptors: Protein folding and coactivator interactions

Molecular Endocrinology

Volumn 17, Issue 1, 2003, Pages 1-10

  Kumar, Raj ^a   Thompson, E Brad ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE RECEPTOR; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR;

BINDING SITE; CARBOXY TERMINAL SEQUENCE; DNA BINDING; DNA RESPONSIVE ELEMENT; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SHORT SURVEY; TRANSCRIPTION INITIATION;

ANIMALS; CELL NUCLEUS; DNA-BINDING PROTEINS; HUMANS; MODELS, MOLECULAR; NUCLEAR PROTEINS; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0037245786     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2002-0258     Document Type: Short Survey

References (98)

1. Anfinsen CB, Scheraga HA 1975 Experimental and theoretical aspects of protein folding. Adv Protein Chem 29:205-300
2. Uversky VN, Gillespie JR, Fink AL 2000 Why are natively unfolded proteins unstructured under physiologic conditions. Proteins 41:415-427
3. Lee H, Mok KH, Muhandiram R, Park KH, Suk JE, Kim DH, Chang J, Sung YC, Choi KY, Han KH 2000 Local structural elements in the mostly unstructured transcriptional activation domain of human p53. J Biol Chem 275:29426-29432
4. Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity. Proc Natl Acad Sci USA 93:11504-11509
5. Weiss MA, Ellenberger T, Wobbe CR, Lee JP, Harrison SC, Struhl K 1990 Folding transition in the DNA-binding domain of GCN4 on specific binding to DNA. Nature 347:575-578
6. Dahlman-Wright, K., Baumann H, McEwan IJ, Almlof T, Wright APH, Gustafsson JÅ, Hard T 1995 Structural characterization of a minimal functional transactjvation domain from the human giucocorticoid receptor. Proc Natl Acad Sci USA 92:1699-1703
7. Baskakov IV, Kumar R, Srinivasan G, Ji Y, Bolen DW, Thompson EB 1999 Trimethylamine N-oxide-induced cooperative folding of an intrinsically unfolded transcription-activating fragment of human glucocorticoid receptor. J Biol Chem 274:10693-10696
8. Bain DL, Franden MA, McManaman JL, Takimoto GS, Horwitz KB 2000 The N-terminal domain of the progesterone A-receptor structural analysis and the influence of the DNA binding domain. J Biol Chem 275:7313-7320
9. Bain DL, Franden MA, McManaman JL, Takimoto GS, Horwitz KB 2001 The N-terminal region of human progesterone B-receptors: biophysical and chemical comparison to A-receptor. J Biol Chem 276:23825-23831
10. Reid J, Kelly SM, Watt K, Price NC, McEwan IJ 2002 Conformational analysis of the androgen receptor amino-terminal domain involved in transactivation. J Biol Chem 277:20079-20086
11. Tell G, Perrone L, Fabbro D, Pellizzari L, Pucillo C, De Felice M, Acquaviva R, Formisano S, Damante G 1998 Structural and functional properties of the N transcriptional activation domain of thyroid transcription factor-1: similarities with the acidic activation domains. Biochem J 329:395-403
12. Donaldson L, and Capone JP 1992 Purification and characterization of the carboxyl-terminal transactivation domain of Vmw65 from herpes simplex virus type 1. J Biol Chem 267:1411-1414
13. Schmitz ML, dos Santos Silva M, Altmann H, Czisch M, Holak TA, Baeuerle PA 1994 Structural and functional analysis of the NF-κ B p65 C terminus. An acidic and modular transactivation domain with the potential to adopt an α-helical conformation. J Biol Chem 269:25613-25620
14. Warnmark A, Wikstrom A, Wright APH, Gustafsson JA, Hard T 2001 The N-terminal regions of estrogen receptor α and β are unstructured in vitro and show different TBP binding properties. J Biol Chem 276:45939-45944
15. McEwan IJ, Dahlman-Wright K, Ford J, Wright APH 1996 Functional interaction of the c-Myc transactivation domain with TATA binding protein: evidence for an induced fit model of transactivation domain folding. Biochemistry 35:9584-9593
16. Shen F, Triezenberg S J, Hensley P, Porter D, Knutson JR 1996 Transcriptional activation domain of the herpesvirus protein VP16 becomes conformationally constrained upon interaction with basal transcription factors. J Biol Chem 271:4827-4837
17. Hovland AR, Powell RL, Takimoto GS, Tung L, Horwitz KB 1998 An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors. J Biol Chem 273:5455-5460
18. Giguere V, Hollenberg SM, Rosenfeld MG, Evans RM 1986 Functional domains of the human glucocorticoid receptor. Cell 46:645-652
19. Tora L, Gronemeyer H, Turcotte B, Gaub MP, Chambon P 1988 The N-terminal region of the chicken progester-one receptor specifies target gene activation. Nature 333:185-188
20. Lees JA, Fawell SE, Parker MG 1989 Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acid Res 17:5477-5487
21. Iniguez-Lluhi JA, Lou DY, Yamamoto KR 1997 Three amino acid substitutions selectively disrupt the activation but not the repression function of the glucocorticoid receptor N terminus. J Biol Chem 272:4149-4156
22. Brzozowski AM, Piki ACW, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, Carlquist M 1997 Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:53-58
23. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D 1995 Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 375:377-82
24. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D 1995 Crystal structure of the retinoic acid receptor-γ ligand binding domain bound to all-trans retinoic acid. Nature 378:681-689
25. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ 1995 A structural role for hormone in the thyroid hormone receptor. Nature 378:690-697
26. Wurtz J-M, Bourguet W, Renaud J-P, Vivat V, Chambon P, Moras D, Gronemeyer HA 1996 Canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol 3:206-212
27. Williams SP Sigler, P 1998 Atomic structure of progesterone complexed with its receptor. Nature 393:392-396
28. Tanenbaum DM, Wang Y, Williams SP, Sigler PB 1998 Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci USA 95:5996-6003
29. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Wilson TM, Glass CK, Milburn MB 1998 Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ. Nature 395:137-143
30. Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, McKee DD, Galardi CM, Plunket KD, Nolte RT, Parks DJ, Moore JT, Kliewer SA, Wilson TM, Stimmel JB 2002 Structural basis for antagonist-mediated recruitment of nuclear corepressors by PPARα. Nature 415:813-817
31. Dey R, Roychowdhury P, Mukherjee C 2001 Homology modeling of the ligand-binding domain of glucocorticoid receptor: binding site interactions with cortisol and corticosterone. Protein Eng 14:565-571
32. Miesfeld R, Godowski PJ, Maler BA, Yamamoto KR 1987 Glucocorticoid receptor mutants that define a small region sufficient for enhancer activation. Science 236:423-427
33. Keightley MC, Fuller PJ 1995 Cortisol resistance and the guinea pig glucocorticoid receptor. Steroids 60:87-92
34. Bocquel MT, Kumar V, Stricker C, Chambon P, Gronemeyer H 1989 The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific. Nucleic Acids Res 17:2581-2595
35. Kumar R, Baskakov IV, Srinivasan G, Bolen DW, Lee JC, Thompson EB 1999 Inter-domain signaling in a two-domain fragment of the human glucocorticoid receptor. J Biol Chem 274:24737-24741
36. Kumar R, Lee JC, Bolen DW, Thompson EB 2001 The conformation of the glucocorticoid receptor AF1/τ1 domain induced by osmolyte binds co-regulatory proteins. J Biol Chem 276:18146-18152
37. Juge-Aubry CE, Kuenzli S, Sanchez JC, Hochstrasser D, Meier CA 2001 Peroxisomal bifunctional enzyme binds and activates the activation function-1 region of the peroxisome proliferator-activated receptor α. Biochem J 353:253-258
38. Folkers GE, van Heerde EC, van der Saag PT 1995 Activation function 1 of retinoic acid receptor β 2 is an acidic activator resembling VP16. J Biol Chem 270:23552-23559
39. Wilkinson JR, Towle HC 1997 Identification and characterization of the AF-1 transactivation domain of thyroid hormone receptor β1. J Biol Chem 272:23824-23832
40. Giguere V, Tini M, Flock G, Ong E, Evans RM, Otulakowski G 1994 Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR a, a novel family of orphan hormone nuclear receptors. Genes Dev 8:536-553
41. Glass CK, Rosenfeld MG 2000 The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14:121-141
42. McKenna NJ, Lanz RB, O'Malley BW 1999 Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20:321-344
43. Tsai MJ, O'Malley BW 1994 Molecular mechanism of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486
44. McDonnell DP, Norris JD 2002 Connections and regulation of the human estrogen receptor. Science 296:1642-1644
45. Hong H, Kohli K, Trivedi A, Johnson DL, Stallcup MR 1996 GRIP-1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of the steroid receptors. Proc Natl Acad Sci USA 93:4948-4952
46. Kamei Y, Xu L, Heizel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG 1996 A CBP integrator complex mediates transcriptional activation and AP1 inhibition by nuclear receptors. Cell 85:403-414
47. Chen H, Lin RJ, Schlitz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM 1997 Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569-580
48. Roeder RG 1996 The role of general initiation factors in transcription by RNA polymerase II. Trends Biosci 21:327-335
49. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L 1996 Nuclear receptor coactivators and corepressors. Mol Endocrinol 10:1167-1177
50. Metivier R, Petit FG, Valotaire Y, Pakdel F 2000 Function of N-terminal transactivation domain of the estrogen receptor requires a potential a-helical structure and is negatively regulated by the A domain. Mol Endocrinol 14:1849-1871
51. Henriksson A, Almlof T, Ford J, McEwan IJ, Gustafsson JA, Wright APH 1997 Role of Ada adapter complex in gene activation by the glucocorticoid receptor. Mol Cell Biol 17: 3065-3073
52. Ford J, McEwan IJ, Wright APH, Gustafsson JA 1997 Involvement of the transcription factor IID protein complex in gene activation by the N-terminal transactivation domain of the glucocorticoid receptor in vitro. Mol Endocrinol 11:1467-1475
53. Almlof T, Wallberg AE, Gustafsson JA, Wright APH 1998 Role of important hydrophobic amino acids in the interaction between the glucocorticoid receptor τ1-core activation domain and target factors. Biochemistry 37:9586-9594
54. Wärnmark A, Gustafsson JA, Wright APH 2000 Architectural principles for the structure and function of the glucocorticoid receptor τ1 core activation domain. J Biol Chem 275:15014-15018
55. Hollenberg SM, Giguère V, Segui P, Evans RM 1987 Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor. Cell 49:39-46
56. Almlof T, Wright APH, Gustafsson JÅ 1995 Role of acidic and phosphorylated residues in gene activation by the glucocorticoid receptor. J Biol Chem 270:17535-17540
57. Dahlman-Wright K, Almlof T, McEwan IJ, Gustafsson JA, Wright APH 1994 Delination of a small region within the major transactivation domain of the human glucocorticold receptor that mediates transactivation of gene expression. Proc Natl Acad Sci USA 91:1619-1623
58. Hope IA, Mahadevan S, Struhl K 1988 Structural and functional characterization of the short acidic transactivation region of yeast GCN4 protein. Science 333:635-640
59. Cress WD, Triezenberg SJ 1991 Critical structural elements of the VP16 transcriptional activation domain. Science 251:87-90
60. Leuther KK, Salmeron JM, Johnston SA 1993 Genetic evidence that an activation domain of GAL4 does not require acidity and may form a β sheet. Cell 72:587-594
61. Regier JL, Shen F, Triezenberg SJ 1993 Pattern of aromatic and hydrophobic amino acids critical for one of two subdomains of the VP16 transcriptional activator. Proc Natl Acad Sci USA 90:883-887
62. Sigler PB 1988 Acid blobs and negative noodles. Nature 333:210-212
63. Almlof T, Gustafsson JA, Wright APH 1997 Role of hydrophobic amino acid clusters in the transactivation activity of the human glucocorticoid receptor. Mol Cell Biol 17:934-945
64. Wrabl JO, Larson SA, Hilser VJ 2001 Thermodynamic propensities of amino acids in the native state ensemble: implications for fold recognition. Protein Sci 10:1032-1045
65. Hilser VJ 2001 Modeling the native state ensemble. Methods Mol Biol 168:93-116
66. Carlson HA, McCammon JA 2000 Accommodating protein flexibility in computational drug design. Mol Pharmacol 57:213-218
67. Webb P, Nguyen P, Shinsako J, Anderson C, Feng W, Nguyen MP, Chen D, Huang SM, Subramanian S, McKinerney E, Katzenellenbogen BS, Stallcup MR, Kushner PJ 1998 Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Mol Endocrinol 12:1605-1618
68. Watanabe M, Yanagisawa J, Kitagawa H, Takeyama K, Ogawa S, Arao Y, Suzawa M, Kato S 2001 A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor coactivator through the N-terminal activation domain (AF1) with an RNA coactivator, SRA. EMBO J 206:1341-1352
69. Hittelman AB, Burakov D, Iniguez-Lluhi JA, Freedman LP, Garabedian MJ 1999 Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. EMBO J 18:5380-5388
70. Robyr D, Wolffe AP, Wahli W 2000 The nuclear hormone receptor coregulators in action: diversity for shared tasks. Mol Endocrinol 14:329-347
71. Lee JW, Lee YC, Na SY, Jung DJ, Lee SK 2001 Transcriptional coregulators of the nuclear receptor superfamily: coactivators and corepressors. Cell Mol Life Sci 58:289-297
72. McKenna NJ, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW 1998 Distinct steady-state nuclear receptor coregulator complexes exist in vivo. Proc Natl Acad Sci USA 95:11697-11702
73. Lanz RB, McKenna N J, Onate SA, Albrecht U, Wong J, Tsai SY, Tsai MJ, O'Malley BW 1999 A steroid receptor coactivator, SRA, functions as an RNA and is present in SRC-1 complex. Cell 97:17-27
74. Weigel N 1996 Steroid hormone receptors and their regulation by phosphorylation. Biochem J 319:657-667
75. Tetel MJ, Giangrande PH, Leonhardt SA, McDonnell DP, Edwards DP 1999 Hormone-dependent interaction between the amino- and carboxyl- terminal domains of progesterone receptor in vitro and in vivo. Mol Endocrinol 13:910-924
76. Ikonen T, Palvimo JJ, Janne OA 1997 Interaction between the amino- and carboxy-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J Biol Chem 272:29821-29828
77. Gandini O, Kohno H, Curtis S, Korach K 1997 Two transcription activation functions in the amino terminus of the mouse estrogen receptor that are affected by the carboxy terminus. Steroids 62:508-515
78. Shao D, Rangwala SM, Bailey ST, Krakow SL, Reginato MJ, Lazar MA 1998 Interdomain communication regulating ligand binding by PPAR-γ. Nature 396:377-380
79. Hall JM, McDonnell DP, Korach KS 2002 Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. Mol Endocrinol 16:469-486
80. Liu Y, Bolen DW 1995 The peptide backbone plays a dominant role in protein stabilization by naturally occurring osmolytes. Biochemistry 34:2884-2891
81. Qu Y, Bolen CL, Bolen DW 1998 Osmolyte-driven contraction of a random coil protein. Proc Natl Acad Sci USA 95:9268-9273
82. Baldwin RL, Rose DG 1999 Is protein folding hierachic? Local structure and peptide folding. Trends Biochem Sci 24:26-33
83. Bia C, Biwersi J, Verkman AS, Matthay MA 1998 A mouse model to test the in vivo efficacy of chemical chaperones. J Pharmacol Toxicol Methods 40:39-45
84. Baskakov IV, Bolen DW 1998 TMAO counteracts urea effects on rabbit muscle LDH function: a test of the counteraction hypothesis. Biophys J 74:2666-2673
85. Baskakov IV, Bolen DW 1998 Forcing thermodynamically unfolded proteins to fold. J Biol Chem 273:4831-4834
86. Yancey PH, Clarke ME, Hand SC, Bowlus RD, Somero GN 1982 Living with water stress; evolution of osmolyte systems. Science 172:1214-1222
87. Burg, MD 1995 Molecular basis of osmolyte regulation. Am J Physiol 268:F983-F996
88. Bolen DW 2001 Protein stabilization by naturally occurring osmolytes. Methods Mol Biol 168:17-36
89. Grad JM, Lyons LS, Robins DM, Burnstein KL 2001 The androgen receptor (AR) amino-terminus imposes androgen-specific regulation of AR gene expression via an exonic enhancer. Endocrinology 142:1107-1116
90. Thackray VG, Lieberman BA, Nordeen SK 1998 Differential gene induction by glucocorticoid and progesterone receptors. J Steroid Biochem Mol Biol 66:171-180
91. Kobayashi Y, Kitamoto T, Masuhiro Y, Watanabe M, Kase T, Metzger D, Yanagisawa J, Kato S 2000 p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor α and β by interacting directly with the N-terminal A/B domains. J Biol Chem 275:15645-15651
92. Metivier R, Penot G, Flouriot G, Pakdel F 2001 Synergism between ERα transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 α-helical core and for a direct interaction between the N- and C-terminal domains. Mol Endocrinol 15:1953-1970
93. 2-terminal interaction with the ligand binding domain of the androgen receptor. J Biol Chem 275:22986-22994
94. 2- and COOH-terminal interaction. J Biol Chem 277:25631-25639
95. 2-terminal domain. J Biol Chem 274:37219-37225
96. Alen P, Claessens F, Verhoeven G, Rombauts W, Peeters B 1999 The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Mol Cell Biol 19:6085-6097
97. Benecke A, Chambon P, Gronemeyer H 2000 Synergy between estrogen receptor a activation functions AF1 and AF2 mediated by transcription intermediary factor TIF2. EMBO Rep 1:151-157
98. Bommer M, Benecke A, Gronemeyer H, Rochette-Egly C 2002 TIF2 mediates the synergy between RARα1 activation functions AF-1 and AF-2. J Biol Chem 277:37961-37966